Viewing nowCrossta Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.

MFDS item code 201400415 · Approved 2014.01.29 · Insurance code 655403180
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when dietary measures and exercise are insufficient for patients with primary hypercholesterolemia and mixed hyperlipidemia. It can also be used in conjunction with dietary measures or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis, and helps reduce total cholesterol, LDL-cholesterol, and Apo-B protein levels in certain pediatric patients. It can also be used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Moreover, it is effective in reducing the risk of stroke, myocardial infarction, and arterial revascularization in men over 50 years and women over 60 years who have elevated high-sensitivity C-reactive protein (hsCRP) levels. In summary, this medication is used for various types of hyperlipidemia and reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Before and during treatment with this medicine, patients should follow a standard cholesterol-lowering diet and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased to a maximum of 20 mg once daily. 3. Older adults: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: Systemic exposure to rosuvastatin did not increase in patients with a Child-Pugh score of 7 or lower, but increased in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on administration of doses greater than 20 mg in pediatric patients.) Maximum 20 mg once daily. The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Younger than 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients with an allergy to any ingredient of this medication, those with severe liver dysfunction, patients with muscle diseases, severely impaired renal function, pregnant or breastfeeding women, and women of childbearing age who do not use adequate contraception should not take this medication. Additionally, patients at risk for myopathy or rhabdomyolysis should avoid high doses. Caution is also necessary for those with a history of hypothyroidism or genetic muscle disorders. Patients with genetic issues like lactose intolerance should not take this medication. This medication can affect liver function, so patients who consume a lot of alcohol or have a history of liver disease should undergo regular liver function tests both before and during treatment. If symptoms like muscle pain or weakness occur, they should inform their doctor immediately, and the medication can be stopped if necessary. This medication may interact with other drugs, so caution is needed when taken alongside medications that may increase muscle toxicity. Some medications can increase this medication's blood levels, raising the risk of side effects, so consultation with a doctor is needed during concomitant therapy. Pregnant or breastfeeding women should not use this medication, and women with potential for pregnancy should use adequate contraception while taking this medication, as it may pose potential risks to the fetus and infant. There is no specific antidote for overdose, so treatment should be symptomatic and liver function and muscle enzyme levels should be monitored. Dizziness or muscle-related symptoms may occur during treatment, so caution is needed when driving or operating machinery. Possible side effects of this medication include headaches, dizziness, muscle pain, dyspepsia, and skin rashes, and in rare cases, severe liver damage or muscle destruction may occur. Therefore, regular check-ups and symptom observation are necessary while taking this medication under the doctor's guidance, and healthcare professionals should be consulted immediately if abnormal symptoms occur.
Angioedema, hypersensitivity reactions, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, fatigue, numbness, paresthesia, chest discomfort, lack of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to store it at room temperature between 1 degree and 30 degrees Celsius.
Yellow round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.